We are live on ! Find out more
ENZY

Enzymotec Ltd
ENZY

Delisted

ENZY was delisted on the 10th of January, 2018.

Back to rankings

18 hedge funds and large institutions have $67.7M invested in Enzymotec Ltd in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

17% more capital invested

Capital invested by funds: $57.8M → $67.7M (+$9.89M)

10% less funds holding

Funds holding: 20 → 18 (-2)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$5.85M
2
Bank of America
Bank of America
North Carolina
+$918K
3
VAM
Visium Asset Management
New York
+$367K
4
Renaissance Technologies
Renaissance Technologies
New York
+$260K
5
MHP
Manatuck Hill Partners
Connecticut
+$206K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.19M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$628K
3
Millennium Management
Millennium Management
New York
-$193K
4
Allianz Asset Management
Allianz Asset Management
Germany
-$112K
5
Stifel Financial
Stifel Financial
Missouri
-$78K

ENZY Hedge Fund Activity: Q2 2015 in Review

18 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q2 2015, worth a combined $67.7M — up 17% from $57.8M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ENZY and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 6 added.

The largest buyer was Goldman Sachs, adding an estimated $5.85M. The largest seller was Fidelity Investments, cutting an estimated $7.19M.

  • 18 institutional investors held Enzymotec Ltd (ENZY) as of Q2 2015, down from 20 in Q1 2015.
  • Funds reported $67.7M of Enzymotec Ltd stock for Q2 2015, up 17% quarter-over-quarter.
  • 2 funds opened new Enzymotec Ltd positions in Q2 2015 and 3 closed out, a net change of -1 holder.
  • The largest Enzymotec Ltd buyer in Q2 2015 was Goldman Sachs, an estimated $5.85M added.
  • The largest Enzymotec Ltd seller in Q2 2015 was Fidelity Investments, an estimated $7.19M sold.

Based on aggregated 13F filings for Q2 2015.